Table 2.
Variable | Lp(a) ≥0.5 g/L | Lp(a) <0.5 g/L | p Value | FH+ | FH– | p Value |
---|---|---|---|---|---|---|
Age, y | 58.7 ± 12.5 | 61.8 ± 13.9 | 0.075 | 56.4 ± 10.6 | 61.6 ± 13.9 | 0.028 |
Male sex | 59.0 | 73.8 | 0.012 | 61.1 | 71.0 | 0.225 |
HTN | 49.4 | 52.8 | 0.595 | 55.6 | 51.3 | 0.627 |
T2DM | 28.9 | 30.9 | 0.736 | 44.4 | 28.3 | 0.047 |
Ever smoked | 36.1 | 40.8 | 0.459 | 41.7 | 39.4 | 0.796 |
Statin at admission | 42.7 | 36.8 | 0.346 | 80.6 | 32.6 | <0.001 |
Cr, μmol/L, median (IQR) | 76.6 (72.3–81.0) | 81.7 (78.0–85.5) | 0.128 | 85.1 (75.5–95.9) | 79.7 (76.6–82.9) | 0.266 |
TC, mmol/L | 5.1 ± 1.4 | 4.8 ± 1.4 | 0.044 | 5.9 ± 1.4 | 4.7 ± 1.2 | <0.001 |
HDL‐C, mmol/L | 1.1 ± 0.3 | 1.0 ± 0.3 | 0.067 | 1.0 ± 0.2 | 1.1 ± 0.3 | 0.733 |
TG, mmol/L, median (IQR) | 1.5 (1.4–1.7) | 1.6 (1.5–1.7) | 0.605 | 2.0 (1.6–2.4) | 1.5 (1.4–1.6) | 0.015 |
LDL‐C, mmol/L | 3.2 ± 1.2 | 2.9 ± 1.1 | 0.011 | 3.9 ± 1.2 | 2.9 ± 1.0 | <0.001 |
Adjusted LDL‐C, mmol/La | 3.7 ± 2.3 | 3.5 ± 1.2 | 0.149 | 6.7 ± 2.0 | 3.1 ± 0.92 | <0.001 |
Non–HDL‐C, mmol/L | 4.0 ± 1.4 | 3.7 ± 1.3 | 0.099 | 4.8 ± 1.4 | 3.6 ± 1.2 | <0.001 |
LDL‐C, mmol/L | ||||||
>1.8 | 90.4 | 80.2 | 0.035 | 100 | 80.6 | 0.004 |
>2.5 | 30.1 | 36.6 | 0.285 | 91.7 | 61.6 | <0.001 |
Lp(a), g/Lb | 0.85 (0.79‐0.92) | 0.13 (0.12‐0.14) | <0.001 | 0.28 (0.19‐0.41) | 0.20 (0.18‐0.22) | 0.062 |
Abbreviations: CI, confidence interval; Cr, creatinine; FH, familial hypercholesterolemia; HDL‐C, high‐density lipoprotein cholesterol; HTN, hypertension; IQR, interquartile range; LDL‐C, low‐density lipoprotein cholesterol; Lp(a), lipoprotein(a); SD, standard deviation; T2DM, type 2 diabetes mellitus; TC, total cholesterol; TG, triglycerides.
Data are presented as percentages or mean ± SD, unless otherwise noted.
LDL‐C adjusted for statin therapy and the cholesterol content of Lp(a).
Data presented as the geometric mean and 95% CI.